Senores Pharmaceuticals' Stellar Stock Market Debut

Senores Pharmaceuticals Ltd witnessed a stellar debut on stock exchanges, with shares surging nearly 43% against the issue price. The Ahmedabad-based company's IPO attracted substantial interest with 93.69 times subscription. Proceeds will support its expansion, including a new facility and strategic acquisitions.

In a remarkable stock market debut, shares of Senores Pharmaceuticals Ltd surged by nearly 43% on Monday, closing at Rs 557.80 on the BSE, a significant rise from the issue price of Rs 391.

The stock, which launched at Rs 593.70, saw a sharp 51.84% increase in value initially, peaking at Rs 609 during the day, before settling on the BSE. Meanwhile, on the NSE, it opened at Rs 600 and closed at Rs 557.05, demonstrating a 42.46% increase.

The Ahmedabad-based firm's initial public offering (IPO), valued at Rs 582 crore, was oversubscribed 93.69 times, marking strong investor confidence. The raised capital is earmarked for a range of strategic initiatives, including building a sterile injection manufacturing facility, supporting working capital, and facilitating strategic growth and acquisition.